site stats

Cytokinetics pharmaceuticals stock

WebMar 7, 2024 · Cytokinetics (Nasdaq:CYTK) earnings and revenue forecasts, price targets, future return on equity. ... President & Director exercised options and sold US$333k worth of stock Aug 04. Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M ... High growth companies in the Pharmaceuticals & Biotech industry. WebDec 20, 2024 · The CSPAs provide for the sale and issuance to the RTW Investors of 511,182 shares of Cytokinetics common stock of (the "Shares") with an aggregate purchase price of $20.0 million at a price per share of $39.125. The closing will occur on December 20, 2024.

Allspring Global Investments Holdings LLC Has $8.88 Million Stake …

WebApr 5, 2024 · CYTOKINETICS, INCORPORATED : News, information and stories for CYTOKINETICS, INCORPORATED Nasdaq: CYTK Nasdaq ... VERTEX PHARMACEUTICALS INCORPORATED : Q1 2024 Earnings Release (Projected) 05/04/23: ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ WebCytokinetics is led by a team of seasoned industry veterans with the shared objective to create the next great biopharmaceutical company that has the potential to change patients’ lives. With significant depth of industry experience and highly complementary skills in diverse fields including drug discovery, clinical research, business ... the privacky murders https://tycorp.net

CYTK - Cytokinetics Inc Stock Price Quote - NASDAQ

WebJan 7, 2024 · Cytokinetics and Royalty Pharma Announce Funding Agreements Totaling up to $450 Million. Royalty Pharma Extends Capitalto Cytokineticsto Support the Commercial Launch of Omecamtiv Mecarbil and the Further Developmentof Aficamten. Royalty Pharma Purchases Royalties on Future Sales of Aficamten. WebApr 5, 2024 · About Cytokinetics (NASDAQ:CYTK) Stock. Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and … WebMar 31, 2024 · Cytokinetics' heart disease drug, aficamten, is a "crown jewel in terms of the pipeline", said Oppenheimer analyst Justin Kim, who expects it could bring more than $1 billion in peak sales from U ... signage companies in benoni

Cytokinetics and Astellas Announce Collaboration in the Field of ...

Category:Cytokinetics - Overview, News & Competitors ZoomInfo.com

Tags:Cytokinetics pharmaceuticals stock

Cytokinetics pharmaceuticals stock

Allspring Global Investments Holdings LLC Has $8.88 Million Stake …

WebApr 9, 2024 · Cytokinetics Trading Up 0.7 %. Cytokinetics stock opened at $36.42 on Friday. The business’s 50 day simple moving average is $39.79 and its 200 day simple moving average is $42.22. WebCytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 36.42 +0.26 (+0.72%) At close: 04:00PM EDT. 35.69 -0.73 ( …

Cytokinetics pharmaceuticals stock

Did you know?

WebApr 10, 2024 · Large Cap Pharmaceuticals stocks are, on average, holding a PEG ratio of 1.73 based on yesterday's closing prices. The Large Cap Pharmaceuticals industry is part of the Medical sector. WebDec 9, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised.

WebApr 11, 2024 · EDMONTON, Alberta, April 11, 2024 -- ( BUSINESS WIRE )--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the United States Patent and Trademark Office... WebApr 9, 2024 · Shares of Cytokinetics stock opened at $36.42 on Friday. The firm’s 50-day moving average price is $39.79 and its two-hundred day moving average price is $42.22. The company has a market ...

WebJan 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.

WebApr 6, 2024 · Company. Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and …

WebCytokinetics Inc (CYTK) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. CYTK Cytokinetics Inc 3,105 $33.36 $0.27 (0.80%) Today Sentiment 0.00% Message Vol. 42.11% Volume (M) 720,685.00 52-Wk High $55.80 52-Wk Low $33.37 About Feed … the pritzlaff milwaukee wiWebApr 10, 2024 · It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have moved down 20.5% compared with the industry’s decline of... the pritzlaff milwaukeeWebApr 29, 2004 · Cytokinetics is registered under the ticker NASDAQ:CYTK . Their stock opened with $13.00 in its Apr 29, 2004 IPO. Cytokinetics is funded by 5 investors. Royalty Pharma and Deerfield are the most recent investors. Cytokinetics has invested in The Mended Hearts on Jan 30, 2024. This investment - Grant - The Mended Hearts - was … signage companies gold coastWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Investor Overview Stock … signage companies around meWebGet the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … the pritzlaff building 333 n plankinton aveWebMar 6, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. the privacy act manitobaWebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated CYTK. Shares of the company have ... signage companies in boksburg